Search Results - Hitaka, Teruaki

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Stronger affinity of reticulocyte release factor than natural suppressor tRNA Ser for the opal termination codon

    Stronger affinity of reticulocyte release factor than natural suppressor tRNA Ser for the opal termination codon by Mizutani, Takaharu, Hitaka, Teruaki

    Published in FEBS letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    The conversion of phosphoserine residues to selenocysteine residues on an opal suppressor tRNA and casein

    The conversion of phosphoserine residues to selenocysteine residues on an opal suppressor tRNA and casein by Mizutani, Takaharu, Hitaka, Teruaki

    Published in FEBS letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The detection of natural opal suppressor seryl-tRNA in Escherichia coli by the dot blot hybridization and its phosphorylation by a tRNA kinase

    The detection of natural opal suppressor seryl-tRNA in Escherichia coli by the dot blot hybridization and its phosphorylation by a tRNA kinase by Mizutani, Takaharu, Maruyama, Naosuke, Hitaka, Teruaki, Sukenaga, Yoshikazu

    Published in FEBS letters
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Stronger affinity of reticulocyte release factor than natural suppressor tRNASer for the opal termination codon

    Stronger affinity of reticulocyte release factor than natural suppressor tRNASer for the opal termination codon by Mizutani, Takaharu, Hitaka, Teruaki

    Published in FEBS letters
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer

    Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer by Kaku, Tomohiro, Hitaka, Takenori, Ojida, Akio, Matsunaga, Nobuyuki, Adachi, Mari, Tanaka, Toshimasa, Hara, Takahito, Yamaoka, Masuo, Kusaka, Masami, Okuda, Teruaki, Asahi, Satoru, Furuya, Shuichi, Tasaka, Akihiro

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: